One reason for the rather minor effects of TKI on local tumour control could be that through heterodimerisation with other receptors of the EGFR-family, e.g. ErbB2, signaltransduction is still possible and therefore exclusively blocking the EGFR-TK is not sufficient [13-15]. This evidence concerns the gene TKT and neoplasm.